According to Intra-Cellular Therapies's latest financial reports the company's current revenue (TTM) is S$0.73 B. In 2023 the company made a revenue of S$0.61 B an increase over the revenue in the year 2022 that were of S$0.33 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.